SCHEMBL7635158

SCHEMBL7635158

Nc1nccc(S(=O)(=O)Cl)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 4/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA6 P23280 1/20 0.40
CA5A P35218 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
CA5B Q9Y2D0 1/20 0.40
KDM4E B2RXH2 3/20 0.39
MAPT P10636 1/20 0.39
HSP90AA1 P07900 3/20 0.38
HRH4 Q9H3N8 1/20 0.38
AURKA O14965 1/20 0.38
PRKACA P17612 1/20 0.38
ADORA2A P29274 1/20 0.38
ALDH1A1 P00352 2/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27849935 0.79 ROCK1 (0.40) ROCK1CA12CA1CA2CA6
SCHEMBL28938658 0.79 ROCK1 (0.45) ROCK1CA12CA1CA2CA6
SCHEMBL331646 0.77 HSP90AA1 (0.46) ROCK1CA12CA1CA2CA6
SCHEMBL2047832 0.77 TDP1 (0.39) KDM4EALDH1A1HSD17B10TDP1
SCHEMBL2044708 0.75 ALDH1A1 (0.38) ALDH1A1HSD17B10TDP1
Diaminopyrimidine SCHEMBL8687813 0.70 ROCK1 (0.46) ROCK1CA12CA1CA2CA6
Diaminopyrimidine SCHEMBL28435113 0.68 ROCK1 (0.41) ROCK1CA12CA1CA2CA6
SCHEMBL7603249 0.67 ALDH1A1 (0.55) CA12CA1CA2CA6CA5A
SCHEMBL29718183 0.67 ALDH1A1 (0.42) KDM4EALDH1A1HSD17B10TDP1
SCHEMBL21906004 0.67 ALDH1A1 (0.42) KDM4EALDH1A1HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020128483-A1 Sulfonamide-containing indole compounds EISAI CO., LTD. 2002-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128483-A1 Sulfonamide-containing indole compounds IDO1, HCCS, VEGFA ROCK1 1073/4885CA12 156/4885CA1 160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.